RhumbLine Advisers’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-43,959
| Closed | -$219K | – | 3151 |
|
|
2021
Q1 | $219K | Sell |
43,959
-1,760
| -4% | -$8.77K | ﹤0.01% | 2807 |
|
|
2020
Q4 | $578K | Buy |
45,719
+6,213
| +16% | +$78.5K | ﹤0.01% | 2385 |
|
|
2020
Q3 | $388K | Sell |
39,506
-6,309
| -14% | -$62K | ﹤0.01% | 2405 |
|
|
2020
Q2 | $456K | Buy |
45,815
+5,466
| +14% | +$54.4K | ﹤0.01% | 2393 |
|
|
2020
Q1 | $357K | Buy |
40,349
+6,155
| +18% | +$54.5K | ﹤0.01% | 2323 |
|
|
2019
Q4 | $315K | Buy |
34,194
+210
| +0.6% | +$1.94K | ﹤0.01% | 2569 |
|
|
2019
Q3 | $200K | Buy |
33,984
+2,998
| +10% | +$17.6K | ﹤0.01% | 2749 |
|
|
2019
Q2 | $372K | Buy |
30,986
+243
| +0.8% | +$2.92K | ﹤0.01% | 2495 |
|
|
2019
Q1 | $371K | Sell |
30,743
-518
| -2% | -$6.25K | ﹤0.01% | 2446 |
|
|
2018
Q4 | $392K | Buy |
31,261
+9,313
| +42% | +$117K | ﹤0.01% | 2406 |
|
|
2018
Q3 | $326K | Buy |
21,948
+311
| +1% | +$4.62K | ﹤0.01% | 2473 |
|
|
2018
Q2 | $364K | Buy |
21,637
+4,124
| +24% | +$69.4K | ﹤0.01% | 2449 |
|
|
2018
Q1 | $401K | Buy |
17,513
+265
| +2% | +$6.07K | ﹤0.01% | 2299 |
|
|
2017
Q4 | $446K | Sell |
17,248
-3,200
| -16% | -$82.7K | ﹤0.01% | 2282 |
|
|
2017
Q3 | $302K | Buy |
20,448
+195
| +1% | +$2.88K | ﹤0.01% | 2551 |
|
|
2017
Q2 | $283K | Buy |
20,253
+1,500
| +8% | +$21K | ﹤0.01% | 2586 |
|
|
2017
Q1 | $320K | Buy |
18,753
+976
| +5% | +$16.7K | ﹤0.01% | 2473 |
|
|
2016
Q4 | $183K | Buy |
17,777
+319
| +2% | +$3.28K | ﹤0.01% | 2698 |
|
|
2016
Q3 | $177K | Buy |
17,458
+210
| +1% | +$2.13K | ﹤0.01% | 2717 |
|
|
2016
Q2 | $194K | Buy |
17,248
+2,414
| +16% | +$27.2K | ﹤0.01% | 2755 |
|
|
2016
Q1 | $203K | Buy |
14,834
+125
| +0.8% | +$1.71K | ﹤0.01% | 2729 |
|
|
2015
Q4 | $279K | Buy |
14,709
+955
| +7% | +$18.1K | ﹤0.01% | 2621 |
|
|
2015
Q3 | $258K | Buy |
13,754
+574
| +4% | +$10.8K | ﹤0.01% | 2642 |
|
|
2015
Q2 | $196K | Buy |
+13,180
| New | +$196K | ﹤0.01% | 2901 |
|